Literature DB >> 9732875

FGF-mediated mesoderm induction involves the Src-family kinase Laloo.

D C Weinstein1, J Marden, F Carnevali, A Hemmati-Brivanlou.   

Abstract

During embryogenesis, inductive interactions underlie the development of much of the body plan. In Xenopus laevis, factors secreted from the vegetal pole induce mesoderm in the adjacent marginal zone; members of both the transforming growth factor-beta (TGF-beta) and fibroblast growth factor (FGF) ligand families seem to have critical roles in this process. Here we report the identification and characterization of laloo, a novel participant in the signal transduction cascade linking extracellular, mesoderm-inducing signals to the nucleus, where alteration of cell fate is driven by changes in gene expression. Overexpression of laloo, a member of the Src-related gene family, in Xenopus embryos gives rise to ectopic posterior structures that frequently contain axial tissue. Laloo induces mesoderm in Xenopus ectodermal explants; this induction is blocked by reagents that disrupt the FGF signalling pathway. Conversely, expression of a dominant-inhibitory Laloo mutant blocks mesoderm induction by FGF and causes severe posterior truncations in vivo. This work provides the first evidence that a Src-related kinase is involved in vertebrate mesoderm induction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9732875     DOI: 10.1038/29808

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  20 in total

1.  Ectopic EphA4 receptor induces posterior protrusions via FGF signaling in Xenopus embryos.

Authors:  Eui Kyun Park; Neil Warner; Yong-Sik Bong; David Stapleton; Ryu Maeda; Tony Pawson; Ira O Daar
Journal:  Mol Biol Cell       Date:  2004-01-23       Impact factor: 4.138

Review 2.  Gutsy moves in mice: cellular and molecular dynamics of endoderm morphogenesis.

Authors:  Manuel Viotti; Ann C Foley; Anna-Katerina Hadjantonakis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-12-05       Impact factor: 6.237

3.  Regulation of early Xenopus development by ErbB signaling.

Authors:  Shuyi Nie; Chenbei Chang
Journal:  Dev Dyn       Date:  2006-02       Impact factor: 3.780

4.  Xenopus FRS2 is involved in early embryogenesis in cooperation with the Src family kinase Laloo.

Authors:  M Kusakabe; N Masuyama; H Hanafusa; E Nishida
Journal:  EMBO Rep       Date:  2001-07-19       Impact factor: 8.807

5.  Induction of ectopic olfactory structures and bone morphogenetic protein inhibition by Rossy, a group XII secreted phospholipase A2.

Authors:  Ignacio Muñoz-Sanjuán; Ali H Brivanlou
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

6.  Xmab21l3 mediates dorsoventral patterning in Xenopus laevis.

Authors:  Jyotsna Sridharan; Tomomi Haremaki; Ye Jin; Sushma Teegala; Daniel C Weinstein
Journal:  Mech Dev       Date:  2012-05-15       Impact factor: 1.882

7.  SNT-1/FRS2alpha physically interacts with Laloo and mediates mesoderm induction by fibroblast growth factor.

Authors:  J Hama; H Xu; M Goldfarb; D C Weinstein
Journal:  Mech Dev       Date:  2001-12       Impact factor: 1.882

8.  Xema, a foxi-class gene expressed in the gastrula stage Xenopus ectoderm, is required for the suppression of mesendoderm.

Authors:  Crystal Suri; Tomomi Haremaki; Daniel C Weinstein
Journal:  Development       Date:  2005-05-18       Impact factor: 6.868

9.  Ligand activation of alternatively spliced fibroblast growth factor receptor-1 modulates pancreatic adenocarcinoma cell malignancy.

Authors:  Selwyn M Vickers; Zhi-Qiang Huang; LeeAnn MacMillan-Crow; Jessica S Greendorfer; John A Thompson
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

10.  Tyrosine phosphorylation of Sprouty proteins regulates their ability to inhibit growth factor signaling: a dual feedback loop.

Authors:  Jacqueline M Mason; Debra J Morrison; Bhramdeo Bassit; Manjari Dimri; Hamid Band; Jonathan D Licht; Isabelle Gross
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.